Shorter Antibiotic Courses Treated Bone Infections Effectively
A 2023 clinical trial found that a seven-day systemic antibiotic course matched the efficacy of longer regimens.
Updated on Sept. 18, 2026 in Arthritis
Live Poll
Do you prefer medical treatments that prioritize shorter recovery times despite potential risks?
The SOLARIO clinical trial, which concluded in August 2023, demonstrated that a seven-day course of systemic antibiotics is as effective as a four-week regimen for treating surgical orthopedic infections when paired with local antibiotic carriers. Results showed comparable treatment failure rates at 12 months for both patient groups.
Why it matters
Reducing systemic antibiotic duration helps lower healthcare costs and decreases the frequency of treatment-linked symptoms. This approach may provide a more efficient standard of care for patients recovering from surgery for orthopedic infections.
The SOLARIO trial tracked 475 patients across 25 sites, finding that the short-duration group experienced fewer antibiotic-linked symptoms at six weeks at 17.2% compared to 45.2% for those on longer courses. Mean hospital stays were also shorter for the short-duration group at 11.9 days versus 14.8 days.
The players
SOLARIO trial
This multi-site clinical trial investigated the efficacy of varying durations of systemic antibiotic therapy for orthopedic infections.
The details
Patients underwent curative surgery for orthopedic infections involving the implantation of a licensed local-antibiotic carrier. Infectious disease specialists at each trial site determined the specific antibiotic combinations used for both systemic and local delivery.
Timeline
The clinical trial began in February 2019 at 25 sites.
The 25-site clinical trial concluded in August 2023.
Patients were assessed for antibiotic-linked symptoms at 6 weeks.
Researchers evaluated treatment failure and survival rates at 12 months.
The Big Picture
This study updates protocols established by the SOLARIO clinical trial regarding the duration of systemic antibiotic therapy. It demonstrates a shift toward shorter, targeted treatment windows to improve patient outcomes while maintaining medical efficacy.
Patients may benefit from shorter hospital stays and a lower likelihood of experiencing symptoms associated with prolonged antibiotic use. These findings offer doctors a evidence-based pathway to reduce medication burdens for individuals undergoing surgical recovery.
The takeaway
Optimizing the duration of systemic antibiotics can significantly reduce the patient experience of treatment-related adverse effects. Implementing these shorter regimens could standardize lower costs and improved recovery timelines for surgical orthopedic patients.
Further reading
For more information on the management of joint and bone conditions, visit the Arthritis section.
Live Poll
Do you prefer medical treatments that prioritize shorter recovery times despite potential risks?
